The ESMO 2025 Congress brings major advances in liver and pancreatic cancer, featuring pivotal trials in hepatocellular carcinoma (HCC), biliary tract cancers (BTC), and pancreatic ductal adenocarcinoma (PDAC). Across these diseases, studies explore ... [10326 chars].. reed more
